By reducing the dose and number of administrations of TGFβ and Cox2 siRNA (3 doses), we could demonstrate the reduction in the tumor was concomitant with an increase in infiltration of CD4+ and CD8+ T-cells into the tumor (Figure 4B–D). The gene discussed is TGFB1; the disease is neoplasm.